OSRH is the ticker symbol for OSR Health, Inc., a publicly traded Healthcare sector company listed on Nasdaq. 13F Pro tracks OSRH with AI-powered analysis, a 32-signal quality score, SEC EDGAR financials, insider transactions, and institutional 13F holdings — all sourced directly from public SEC filings.

Is OSRH a good stock to buy?

OSRH is tracked on 13F Pro with SEC EDGAR data, but is not currently included in our 32-signal AI quality ranking. The full company profile with financials and AI insights is at https://13fpro.ai/company/OSRH.

Where does 13F Pro source OSRH data?

All OSR Health, Inc. fundamentals and ownership data come directly from SEC EDGAR. OSR Health, Inc. files with the SEC under CIK 1840425. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

OSR Health, Inc.(OSRH)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

OSR Health, Inc. (OSRH) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. OSRH is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $3.5m in revenue and is scored on the micro-cap board instead. Based on the latest XBRL financial filings (Q2 2026), OSR Health, Inc. reports quarterly revenue of $315.7K, net income of $-1.0M. Top institutional holders of OSRH by reported 13-F value include VANGUARD FIDUCIARY, CITADEL ADVISORS, JANE STREET GROUP, based on the most recent SEC filings. OSRH trades on the Nasdaq exchange and files with the SEC under CIK 1840425. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate OSRH daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for OSR Health, Inc. directly from SEC EDGAR.

Revenue

$315.7K

Net Income

$-1.0M

OSRH key financials by period

OSR Health, Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
Period	Form	Revenue	Net income	Operating margin
FY 2025	10-K	$2.9M	—	—
FY 2024	10-K	$3.5M	$-2.4M	—

Institutions holding OSRH

Institutional investors reporting a position in OSR Health, Inc. on SEC Form 13F.
Institution	Shares	Value	Reported
VANGUARD FIDUCIARY	148,266	$46.9K	2026-06-30
CITADEL ADVISORS	127,810	$40.4K	2026-06-30
JANE STREET GROUP	127,195	$40.2K	2026-06-30
GEODE CAPITAL MANAGEMENT	100,458	$31.8K	2026-06-30
TWO SIGMA SECURITIES	46,537	$14.7K	2026-06-30
VANGUARD CAPITAL MANAGEMENT	37,373	$11.8K	2026-06-30
XTX Topco Ltd	32,380	$10.2K	2026-06-30
SUSQUEHANNA INTERNATIONAL GROUP, LLP	18,282	$5.8K	2026-06-30
NORTHERN	10,906	$3.5K	2026-06-30
Tower Research Capital (TRC)	6,587	$2.1K	2026-06-30

SEC EDGAR: CIK 1840425 →

OSR Health, Inc.

OSRH

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $3.5M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.